Edition:
United Kingdom

Essity AB (publ) (ESSITYb.ST)

ESSITYb.ST on Stockholm Stock Exchange

235.70SEK
21 Sep 2018
Change (% chg)

5.70kr (+2.48%)
Prev Close
230.00kr
Open
230.00kr
Day's High
235.70kr
Day's Low
229.40kr
Volume
2,195,659
Avg. Vol
1,224,286
52-wk High
253.60kr
52-wk Low
210.90kr

Latest Key Developments (Source: Significant Developments)

Essity sees significantly higher raw material costs in Q3 - CEO
Thursday, 19 Jul 2018 

July 19 (Reuters) - Essity AB (publ) ::ESSITY CEO SAYS SEES SIGNIFICANTLY HIGHER RAW MATERIAL COSTS IN Q3 VERSUS Q2 AND VERSUS Q3 2017.ESSITY CEO SAYS NEW PLANNED PRICE INCREASES TO COMPENSATE FOR PULP COSTS WILL HAVE A SLIGHT IMPACT 2018, MOST OF THE IMPACT WILL COME IN 2019.ESSITY CEO SAYS THERE IS A HIGHER ACCEPTANCE IN THE MARKET CURRENTLY FOR PRICE INCREASES.ESSITY CEO SAYS HAS ALREADY ACHIEVED SOME FURTHER PRICE INCREASES FOR NEXT YEAR IN EUROPE WITHIN CONSUMER TISSUE.ESSITY CEO SAYS IN EMERGING MARKETS, CONSUMER TISSUE DIVISION TO INCREASE FOCUS ON PREMIUM, SUPER PREMIUM SEGMENTS.ESSITY CEO SAYS COMPANY WILL BE BACK IN SHAPE TO START DOING ACQUISITIONS IN 2019.  Full Article

Essity Wins A Contract From NASA
Tuesday, 10 Jul 2018 

July 10 (Reuters) - Essity AB (publ) ::WINS NASA CONTRACT TO DESIGN NEXT-GENERATION JOBST COMPRESSION ORTHOSTATIC INTOLERANCE GARMENT FOR POTENTIAL USE ON FUTURE ORION HUMAN DEEP-SPACE MISSIONS.  Full Article

Essity CEO: Price hikes in Europe to have full impact from H2
Friday, 27 Apr 2018 

April 27 (Reuters) - Essity AB CEO Magnus Groth and CFO Fredrik Rystedt in earnings call with analysts and media ::ESSITY CEO SAYS PRICE INCREASES ACHIEVED RECENTLY IN EUROPE WILL HAVE SOME IMPACT IN Q2 AND FULL IMPACT IN H2.ESSITY CEO SAYS WORKING TO CORRECT NEGATIVE VOLUME IMPACT IN NORTH AMERICA FROM PERHAPS TOO AMBITIOUS PRICE INCREASES.ESSITY CEO SAYS REGAINING SOME MARKET SHARE ON INCONTINENCE CARE PRODUCTS IN RETAIL IN EUROPE.ESSITY CFO SAYS PULP PRICES REMAIN CHALLENGING IN CONSUMER TISSUE AS PRICES CONTINUE TO RISE.  Full Article

Essity says restructures in Spain, sees costs of around SEK 245 mln
Thursday, 5 Apr 2018 

April 5 (Reuters) - Essity AB (publ) ESSITYb.ST::SAYS RESTRUCTURES IN SPAIN.SAYS ‍ESSITY IS RESTRUCTURING ITS CONSUMER TISSUE PRODUCTION IN SPAIN​.‍MEASURES TO BE IMPLEMENTED IN 2018 INCLUDE CLOSURE OF PRODUCTION FACILITY IN LA RIBA​.SAYS ‍RESTRUCTURING COSTS ARE EXPECTED TO AMOUNT TO APPROXIMATELY SEK 245 MLN, OF WHICH APPROXIMATELY SEK 205 MLN WILL BE RECOGNIZED AS AN ITEM AFFECTING COMPARABILITY IN Q2 OF 2018​.‍MEASURES TO BE IMPLEMENTED IN 2018 INCLUDE CLOSURE OF ONE TISSUE MACHINE AT PRODUCTION FACILITY IN ALLO​.‍APPROXIMATELY SEK 110 MLN OF RESTRUCTURING COSTS IS EXPECTED TO AFFECT CASH FLOW​.SAYS ‍REMAINING COSTS WILL BE RECOGNIZED AS AN ITEM AFFECTING COMPARABILITY IN Q4 OF 2018​.  Full Article

Essity CFO: Personal Care impacted by lower prices also in Q4
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Essity CEO Magnus Groth, CFO Fredrik Rystedt to analysts and media in a conference call:Essity ceo says we are initiating price increases in consumer tissue, this will not benefit q4 or q1 but the latter part of 2018.Essity cfo says personal care will see impact also in q4 from this year's price declines.Essity cfo says judgment is that raw material costs will be significantly higher in q4 versus year-ago quarter.Essity cfo says sees fy 2017 capital expenditure at roughly 6.5 billion sek.  Full Article

Essity Jan-Sept ‍adjusted EBITA slightly above expectations
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Essity Ab (Publ) :Essity ab (publ) 9m ‍adjusted operating profit before amortization of acquisition-related intangible assets (ebita) rose 11% to sek 9,786m​.9 m ‍net sales increased 8.2% to sek 80,601m (74,466)​.Essity ab (publ) q3 ‍organic sales increased by 1.8%, of which volume accounted for 2.2% and price/mix for -0.4%​.Reuters poll: essity jan-sept adjusted ebita seen at 9.69 billion sek, sales at 81.1 billion.  Full Article

Photo

Pulp problems: Why shoppers may pay more for tissues, toilet paper

CHICAGO/LONDON With toilet roll and tissues swept up in an escalating international trade row, it's not just Procter & Gamble's Charmin that's going to get the squeeze.